Drug Distributors' Order Reporting Had Flaws, Expert Testifies

A former DEA official testified Monday in a Washington state opioid trial that at least one of the "Big Three" drug distributors raised pharmacy controlled-substance order caps for unjustifiable reasons, and...

Already a subscriber? Click here to view full article